News Center
Lizhu R&D has won another award
Release time:
2018-07-06
Honesty is the principle of being a person, credit is the soul of society, and innovation is the foundation of enterprises. In the 33 years of the flowing river of Lizhu Pharmaceutical, the Lizhu Deler brand was established in 1989, and in 1999, the Shenqi Fuzheng injection was approved for formal production, subsequently winning the "First Prize for Scientific and Technological Progress in Guangdong Province and the Second Prize for National Scientific and Technological Progress"; in 2001, the antiviral granules won the "First Prize for Science and Technology from the Chinese Association of Traditional Chinese Medicine"; in 2005, Lishenbao (injectable urinary follicle-stimulating hormone) won the "Second Prize for Scientific and Technological Progress in Guangdong Province"; the original innovative drug Aiprazole also won the "First Prize for Scientific and Technological Progress in Guangdong Province and the Second Prize for National Scientific and Technological Progress".
|
Honesty is the principle of being a person, credit is the soul of society, and innovation is the foundation of enterprises.In the 33 years of LIZHU Pharmaceutical's flowing river, the LIZHU Deler brand was established in 1989. In 1999, the Shenqi Fuzheng injection was approved for formal production and successively won the "First Prize for Scientific and Technological Progress in Guangdong Province and the Second Prize for National Scientific and Technological Progress"; In 2001, the antiviral granules won the "First Prize for Science and Technology from the Chinese Association of Traditional Chinese Medicine"; In 2005, Lishenbao (injectable urinary follicle-stimulating hormone) won the "Second Prize for Scientific and Technological Progress in Guangdong Province"; The original new drug Aiprazole also successively won the "First Prize for Scientific and Technological Progress in Guangdong Province and the Second Prize for National Scientific and Technological Progress." With the changes of history and the rise of new drugs, the earth-shaking changes in LIZHU Pharmaceutical cannot be separated from the efforts of our R&D team. On June 29-30, 2018, at the Third China Pharmaceutical R&D Innovation Summit,the LIZHU Pharmaceutical Group was awarded the "Top 10 in China's Biopharmaceutical R&D Strength in 2018", "Top 100 in China's Chemical Drug R&D Strength in 2018", and "Top 20 in China's General Strength of Drug R&D in 2018" by the organizing committee of the China Pharmaceutical R&D Innovation Summit and the China Pharmacy Magazine based on the evaluation of drug R&D strength rankings. This is after LIZHU won the top 10 in the field of biopharmaceutical R&D, the top 100 in the field of chemical drugs, and the top 20 in general strength in 2017, LIZHU has won this award again. The group's chief scientist, Wen Hong, represented LIZHU to accept the award. 集团首席科学家温弘代表丽珠领奖。
|
Related Information